Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency

Journal of Bone and Mineral Research

Volumn 12, Issue 2, 1997, Pages 210-220

  Magnusson, Per ^a   Degerblad, Marie ^b   Sääf, Maria ^b   Larsson, Lasse ^a   Thorén, Marja ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; BONE GROWTH; BONE MINERAL; BONE REMODELING; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CROSS LINKING; FEMALE; GROWTH HORMONE DEFICIENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MARKER GENE; OSTEOBLAST;

ADULT; AGED; ALKALINE PHOSPHATASE; BONE AND BONES; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; ISOENZYMES; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDE FRAGMENTS; PROCOLLAGEN; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 0031020048     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.2.210     Document Type: Article

References (59)

1. Kassem M, Blum W, Risteli J, Mosekilde L, Eriksen EF 1993 Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52:222-226.
2. Baylink DJ, Finkelman RD, Mohan S 1993 Growth factors to stimulate bone formation. J Bone Miner Res 8(Suppl 2): S565-S572.
3. De Boer H, Blok G-J, Van der Veen EA 1995 Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86.
4. Degerblad M, Bengtsson B-Å, Bramnert M, Johnell O, Manhem P, Rosén T, Thorén M 1995 Reduced bone mineral density in adults with growth hormone (GH) deficiency: Increased bone turnover during 12 months of GH substitution therapy. Eur J Endocrinol 133:180-188.
5. Johansen JS, Pedersen SA, Jørgensen JOL, Riis BJ, Christiansen C, Christiansen JS, Skakkebask NE 1990 Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab 70:916-919.
6. Schlemmer A, Johansen JS, Pedersen SA, Jørgensen JOL, Hassager C, Christiansen C 1991 The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol 35:471-476.
7. Binnerts A, Swart GR, Wilson JHP, Hoogerbrugge N, Pois HAP, Birkenhager JC, Lamberts SWJ 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol 37:79-87.
8. Beshyah SA, Kyd P, Thomas E, Fairney A, Johnston DG 1995 The effects of prolonged growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults. Clin Endocrinol 42:249-254.
9. Sartorio A, Conti A, Monzani M, Morabito F, Faglia G 1993 Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover. J Endocrinol Invest 16:893-898.
10. Degerblad M, Elgindy N, Hall K, Sjöberg H-E, Thorén M 1992 Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol (Copenhagen) 126:387-393.
11. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM 1993 Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 76: 1344-1348.
12. Vandeweghe M, Taelman P, Kaufman J-M 1993 Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 39:409-415.
13. Nielsen HK, Jørgensen JOL, Brixen K, Christiansen JS 1991 Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: Dose-response studies with biosynthetic human GH. Calcif Tissue Int 48:82-87.
14. Juul A, Pedersen SA, Sørensen S, Winkler K, Jørgensen JOL, Christiansen JS, Skakkebæk NE 1994 Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset. Eur J Endocrinol 131:41-49.
15. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A 1990 A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res 5:609-618.
16. Millán JL, Fishman WH 1995 Biology of human alkaline phosphatases with special reference to cancer. Crit Rev Clin Lab Sci 32:1-39.
17. Moss DW 1992 Perspectives in alkaline phosphatase research. Clin Chem 38:2486-2492.
18. Miura M, Sakagishi Y, Hata K, Komoda T 1994 Differences between the sugar moieties of liver-and bone-type alkaline phosphatases: A re-evaluation. Ann Clin Biochem 31:25-30.
19. Robison R 1923 The possible significance of hexosephosphoric esters in ossification. Biochem J 17:286-293.
20. Vittur F, Stagni N, Moro L, De Bernard B 1984 Alkaline phosphatase binds to collagen: A hypothesis on the mechanism of extravesicular mineralization in epiphyseal cartilage. Experientia 40:836-837.
21. Wu LNY, Genge BR, Wuthier RE 1992 Evidence for specific interaction between matrix vesicle proteins and the connective tissue matrix. Bone Miner 17:247-252.
22. Bellows CG, Aubin JE, Heersche JNM 1991 Initiation and progression of mineralization of bone nodules formed in vitro: The role of alkaline phosphatase and organic phosphate. Bone Miner 14:27-40.
23. Harrison G, Shapiro IM, Golub EE 1995 The phosphatidyl-inositol-glycolipid anchor on alkaline phosphatase facilitates mineralization initiation in vitro. J Bone Miner Res 10: 568-573.
24. Makiya R, Stigbrand T 1992 Placental alkaline phosphatase as the placental IgG receptor. Clin Chem 38:2543-2545.
25. Magnusson P, Löfman O, Larsson L 1992 Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J Chromatogr 576:79-86.
26. Magnusson P, Löfman O, Larsson L 1993 Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography. Anal Biochem 211:156-163.
27. Kowarski A, Thompson RG, Migeon CJ, Blizzard RM 1971 Determination of integrated plasma concentrations and true secretion rates of human growth hormone. J Clin Endocrinol Metab 32:356-360.
28. Hilding A, Brismar K, Degerblad M, Thorén M, Hall K 1995 Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin dependent diabetic patients compared to that in healthy subjects. J Clin Endocrinol Metab 80:2646-2652.
29. Thorén MC, Wivall-Helleryd I-L, Slum WF, Hall KE 1994 Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency. Eur J Endocrinol 131:33-40.
30. Bretaudière J-P, Vassault A, Amsellem L, Pourci M-L, Thieu-Phung H, Bailly M 1977 Criteria for establishing a standardized method for determining alkaline phosphatase activity in human serum. Clin Chem 23:2263-2274.
31. Luthman M, Jónsdóttir I, Skoog B, Wivall I-L, Roos P, Werner S 1990 Monoclonal antibodies reveal circulating growth hormone of high molecular weight not detectable by conventional assays. Acta Endocrinol (Copenhagen) 123:317-325.
32. Cerasi E, Della Casa L, Luft R, Roovete A 1966 Determination of human growth hormone (HGH) in plasma by a double antibody radioimmunoassay. Acta Endocrinol (Copenhagen) 53:101-120.
33. Bang P, Eriksson U, Sara V, Wivall I-L, Hall K 1991 Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinol (Copenhagen) 124: 620-629.
34. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM 1994 Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 40:358-363.
35. Melkko J, Niemi S, Risteli L, Risteli J 1990 Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332.
36. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L 1993 Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640.
37. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF 1993 Immunoassay for urinary pyridinoline: The new marker of bone resorption. J Bone Miner Res 8:635-641.
38. Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F 1993 Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 8:643-648.
39. Goverde BC, Veenkamp FJN 1972 Routine assay of total urinary hydroxyproline based on resin-catalysed hydrolysis. Clin Chim Acta 41:29-40.
40. Stein GS, Lian JB, Owen TA 1990 Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111-3123.
41. Stein GS, Lian JB 1993 Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442.
42. McComb RB, Bowers GN Jr, Posen S 1979 Alkaline Phosphatase. Plenum Press, New York, NY, U.S.A., pp. 542-543.
43. Lueken SA, Arnaud SB, Taylor AK, Baylink DJ 1993 Changes in markers of bone formation and resorption in a bed rest model of weightlessness. J Bone Miner Res 8:1433-1438.
44. Nishimura Y, Fukuoka H, Kiriyama M, Suzuki Y, Oyama K, Ikawa S, Higurashi M, Gunji A 1994 Bone turnover and calcium metabolism during 20 days bed rest in young healthy males and females. Acta Physiol Scand 150(Suppl 616):27-35.
45. Pedersen BJ, Schlemmer A, Hassager C, Christiansen C 1995 Changes in the carboxyl-terminal propeptide of type I procollagen and other markers of bone formation upon five days of bed rest. Bone 17:91-95.
46. Ebeling PR, Jones JD, O'Fallon WM, Janes CH, Riggs BL 1993 Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 77:1384-1387.
47. Johansson AG, Lindh E, Blum WF, Kollerup G, Sørensen OH, Ljunghall S 1996 Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J Clin Endocrinol Metab 81:44-48.
48. Johansson AG, Lindh E, Ljunghall S 1992 Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 339:1619.
49. Rosalki SB, Foo AY 1984 Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem 30:1182-1186.
50. Rosalki SB, Foo AY 1986 Simplified wheat germ lectin precipitation method for alkaline phosphatase isoenzyme. Clin Chem 32:2118.
51. Rosalki SB, Foo AY 1989 Effect of Triton X-100 on precipitation of biliary phosphatase by wheat-germ lectin. Clin Chem 35:513.
52. Garrido JC, Aguayo FJ, Moreno CA 1992 Comparison of three bone alkaline phosphatase quantification methods in patients with increased alkaline phosphatase activities. Clin Chem 38:1165-1166.
53. Black J, Oldfield S 1994 Is it liver or is it bone alkaline phosphatase? Clin Chem 40:1120 (abstract).
54. Rosalki SB, Foo AY, Burlina A, Prellwitz W, Stieber P, Neumeier D, Klein G, Poppe WA, Bodenmüller H 1993 Multicenter evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase activity in serum and plasma. Clin Chem 39:648-652.
55. Magnusson P, Hager A, Larsson L 1995 Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents. Pediatr Res 38:955-961.
56. Magnusson P, Löfman O, Toss G, Larsson L 1995 Determination of bone alkaline phosphatase isoforms in serum by a new high-performance liquid chromatography assay in patients with metabolic bone disease. Acta Orthop Scand 66(Suppl 266): 203-204.
57. Nishiyama K, Sugimoto T, Kaji H, Kanatani M, Kobayashi T, Chihara K 1996 Stimulatory effect of growth hormone on bone resorption and osteoclast differentiation. Endocrinology 137:35-41.
58. Sakano S, Murata Y, Miura T, Iwata H, Sato K, Matsui N, Seo H 1993 Collagen and alkaline phosphatase gene expression during bone morphogenetic protein (BMP)-induced cartilage and bone differentiation. Clin Orthop (292):337-344.
59. Zhou H, Choong P, McCarthy R, Chou ST, Martin TJ, Ng KW 1994 In situ hybridization to show sequential expression of osteoblast gene markers during bone formation in vivo. J Bone Miner Res 9:1489-1499.